Clinical Trials in Denizli, Turkey (Türkiye)
12 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC614 enrolled217 locationsNCT06170788
Recruiting
Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Multiple Myeloma
Janssen Research & Development, LLC795 enrolled242 locationsNCT06208150
Recruiting
Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Janssen Research & Development, LLC1,590 enrolled261 locationsNCT05552222
Recruiting
The Investigation of Kinesiophobia in Conservative Distal Radius Fractures
Distal Radius FractureKinesiophobiaFunctional Status
Pamukkale University34 enrolled2 locationsNCT07291505
Recruiting
Not Applicable
Tai Chi and Square-Stepping Exercises in Women With Multiple Sclerosis
Multiple Sclerosis
Pamukkale University39 enrolled1 locationNCT07461987
Recruiting
Not Applicable
Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL
Pamukkale University45 enrolled1 locationNCT07154043
Recruiting
Phase 3
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Novartis Pharmaceuticals1,400 enrolled193 locationsNCT05827081
Recruiting
Phase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-small Cell Lung Cancer (NSCLC)
Amgen750 enrolled379 locationsNCT05920356
Recruiting
Phase 1Phase 2
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Non-Small-Cell Lung Carcinoma
AbbVie252 enrolled55 locationsNCT06772623
Recruiting
Sexual Functıon in Young Women After Breast Cancer Surgery
Breast Cancer SurgeryYoung Adult Females
ATİYE KAŞ ÖZDEMİR52 enrolled1 locationNCT06966791
Recruiting
RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
Liver Cancer, Adult
Ankara University150 enrolled20 locationsNCT07345247
Recruiting
Phase 3
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Hepatitis CHepatitis C, ChronicHepatitis C Virus Infection+1 more
Atea Pharmaceuticals, Inc.880 enrolled89 locationsNCT07037277
Recruiting
Not Applicable
Virtual Reality in COPD Exacerbation
Pulmonary RehabilitationCOPD Exacerbation
Pamukkale University50 enrolled1 locationNCT05687396